Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial

IntroductionDespite optimal treatment, patients with chronic coronary artery disease (CAD) and diabetes mellitus (DM) are at high risk of cardiovascular events, emphasizing the need for new treatment options. The Low-Dose Colchicine 2 (LoDoCo2) trial demonstrated that colchicine reduces cardiovascul...

Full description

Bibliographic Details

Published in:	Frontiers in Cardiovascular Medicine
Main Authors:	Niekbachsh Mohammadnia, Jan Los, Tjerk S. J. Opstal, Aernoud T. L. Fiolet, John W. Eikelboom, Arend Mosterd, Stefan M. Nidorf, Charley A. Budgeon, Jan G. P. Tijssen, Peter L. Thompson, Cees J. Tack, Suat Simsek, Willem A. Bax, Jan H. Cornel, Saloua El Messaoudi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-10-01
Subjects:	diabetes mellitus coronary artery disease colchicine inflammation prevention
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1244529/full